Dynamin 2-dependent Endocytosis is Required for Normal Megakaryocyte Development in Mice

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2014 Dec 4

PMID 25468568

Citations 26

Authors

Markus Bender

Silvia Giannini

Renata Grozovsky

Terese Jonsson

Hilary Christensen

Fred G Pluthero

Amy Ko

Ann Mullally

Walter H A Kahr

Karin M Hoffmeister

Herve Falet

Affiliations

Soon will be listed here.

Abstract

Dynamins are highly conserved large GTPases (enzymes that hydrolyze guanosine triphosphate) involved in endocytosis and vesicle transport, and mutations in the ubiquitous and housekeeping dynamin 2 (DNM2) have been associated with thrombocytopenia in humans. To determine the role of DNM2 in thrombopoiesis, we generated Dnm2(fl/fl) Pf4-Cre mice specifically lacking DNM2 in the megakaryocyte (MK) lineage. Dnm2(fl/fl) Pf4-Cre mice had severe macrothrombocytopenia with moderately accelerated platelet clearance. Dnm2-null bone marrow MKs had altered demarcation membrane system formation in vivo due to defective endocytic pathway, and fetal liver-derived Dnm2-null MKs formed proplatelets poorly in vitro, showing that DNM2-dependent endocytosis plays a major role in MK membrane formation and thrombopoiesis. Endocytosis of the thrombopoietin receptor Mpl was impaired in Dnm2-null platelets, causing constitutive phosphorylation of the tyrosine kinase JAK2 and elevated circulating thrombopoietin levels. MK-specific DNM2 deletion severely disrupted bone marrow homeostasis, as reflected by marked expansion of hematopoietic stem and progenitor cells, MK hyperplasia, myelofibrosis, and consequent extramedullary hematopoiesis and splenomegaly. Taken together, our data demonstrate that unrestrained MK growth and proliferation results in rapid myelofibrosis and establishes a previously unrecognized role for DNM2-dependent endocytosis in megakaryopoiesis, thrombopoiesis, and bone marrow homeostasis.

Citing Articles

Bipotential B-neutrophil progenitors are present in human and mouse bone marrow and emerge in the periphery upon stress hematopoiesis.

Shahbaz S, Rosero E, Syed H, Hnatiuk M, Bozorgmehr N, Rahmati A mBio. 2024; 15(8):e0159924.

PMID: 39012145 PMC: 11323571. DOI: 10.1128/mbio.01599-24.

New insights of platelet endocytosis and its implication for platelet function.

Zhou Y, Dong J, Wang M, Liu Y Front Cardiovasc Med. 2024; 10:1308170.

PMID: 38264257 PMC: 10803655. DOI: 10.3389/fcvm.2023.1308170.

Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice.

Eaton N, Boyd E, Biswas R, Lee-Sundlov M, Dlugi T, Ramsey H Front Oncol. 2022; 12:959806.

PMID: 36110936 PMC: 9468709. DOI: 10.3389/fonc.2022.959806.

Genetic Knock-out of TNFR1 and TNFR2 in a JAK2-V617F Polycythemia Vera Mouse Model.

Muller P, Baldauf C, Haage T, Charakopoulos E, Bottcher M, Bhuria V Hemasphere. 2022; 6(5):e717.

PMID: 35449791 PMC: 9015207. DOI: 10.1097/HS9.0000000000000717.

Don't you forget about me(gakaryocytes).

Tilburg J, Becker I, Italiano J Blood. 2021; 139(22):3245-3254.

PMID: 34582554 PMC: 9164737. DOI: 10.1182/blood.2020009302.

References

Pronk C, Rossi D, Mansson R, Attema J, Norddahl G, Chan C . Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell. 2008; 1(4):428-42. DOI: 10.1016/j.stem.2007.07.005. View

Hitchcock I, Chen M, King J, Kaushansky K . YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation. Blood. 2008; 112(6):2222-31. PMC: 2532800. DOI: 10.1182/blood-2008-01-134049. View

Claeys K, Zuchner S, Kennerson M, Berciano J, Garcia A, Verhoeven K . Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain. 2009; 132(Pt 7):1741-52. PMC: 2724916. DOI: 10.1093/brain/awp115. View

Bitoun M, Durieux A, Prudhon B, Bevilacqua J, Herledan A, Sakanyan V . Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. Hum Mutat. 2009; 30(10):1419-27. DOI: 10.1002/humu.21086. View

Rumjantseva V, Grewal P, Wandall H, Josefsson E, Sorensen A, Larson G . Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med. 2009; 15(11):1273-80. PMC: 4428152. DOI: 10.1038/nm.2030. View

Saur S, Sangkhae V, Geddis A, Kaushansky K, Hitchcock I . Ubiquitination and degradation of the thrombopoietin receptor c-Mpl. Blood. 2009; 115(6):1254-63. PMC: 2826235. DOI: 10.1182/blood-2009-06-227033. View

Akada H, Yan D, Zou H, Fiering S, Hutchison R, Mohi M . Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease. Blood. 2010; 115(17):3589-97. PMC: 2867267. DOI: 10.1182/blood-2009-04-215848. View

Eliades A, Papadantonakis N, Ravid K . New roles for cyclin E in megakaryocytic polyploidization. J Biol Chem. 2010; 285(24):18909-17. PMC: 2881813. DOI: 10.1074/jbc.M110.102145. View

Mullally A, Lane S, Ball B, Megerdichian C, Okabe R, Al-Shahrour F . Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell. 2010; 17(6):584-96. PMC: 2909585. DOI: 10.1016/j.ccr.2010.05.015. View

10.

Mazharian A, Thomas S, Dhanjal T, Buckley C, Watson S . Critical role of Src-Syk-PLC{gamma}2 signaling in megakaryocyte migration and thrombopoiesis. Blood. 2010; 116(5):793-800. DOI: 10.1182/blood-2010-03-275990. View

11.

Marty C, Lacout C, Martin A, Hasan S, Jacquot S, Birling M . Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice. Blood. 2010; 116(5):783-7. DOI: 10.1182/blood-2009-12-257063. View

12.

Falet H, Pollitt A, Jurak Begonja A, Weber S, Duerschmied D, Wagner D . A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function. J Exp Med. 2010; 207(9):1967-79. PMC: 2931168. DOI: 10.1084/jem.20100222. View

13.

Li J, Spensberger D, Ahn J, Anand S, Beer P, Ghevaert C . JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood. 2010; 116(9):1528-38. PMC: 3145111. DOI: 10.1182/blood-2009-12-259747. View

14.

Levine R, Gilliland D . Myeloproliferative disorders. Blood. 2008; 112(6):2190-8. PMC: 2962533. DOI: 10.1182/blood-2008-03-077966. View

15.

Reems J, Wang W, Tsubata K, Abdurrahman N, Sundell B, Tijssen M . Dynamin 3 participates in the growth and development of megakaryocytes. Exp Hematol. 2008; 36(12):1714-27. PMC: 2728587. DOI: 10.1016/j.exphem.2008.08.010. View

16.

Michalak M, Groenendyk J, Szabo E, Gold L, Opas M . Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J. 2009; 417(3):651-66. DOI: 10.1042/BJ20081847. View

17.

Lannutti B, Epp A, Roy J, Chen J, Josephson N . Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis. Blood. 2008; 113(8):1778-85. PMC: 2647669. DOI: 10.1182/blood-2007-11-124859. View

18.

Tiedt R, Coers J, Ziegler S, Wiestner A, Hao-Shen H, Bornmann C . Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood. 2008; 113(8):1768-77. DOI: 10.1182/blood-2008-03-146084. View

19.

Zoncu R, Perera R, Balkin D, Pirruccello M, Toomre D, De Camilli P . A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell. 2009; 136(6):1110-21. PMC: 2705806. DOI: 10.1016/j.cell.2009.01.032. View

20.

Besancenot R, Chaligne R, Tonetti C, Pasquier F, Marty C, Lecluse Y . A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation. PLoS Biol. 2010; 8(9). PMC: 2935456. DOI: 10.1371/journal.pbio.1000476. View